Form 13-F position report

TRILLIUM THERAPEUTICS INC

Reported by BAKER BROS ADVISORS LP

CUSIP 89620X506 Manager CIK 0001263508

Reported 0 shares, down 1,100,000 (100.0%) from the prior quarter.

Reported value -100.0%; share count -100.0% vs. the prior quarter.

Reduced
% of reported 13F value 0 This manager · Q1 2020
Shares 0 Quarter-end amount reported
Reported value $0 Fair value at quarter end
Consecutive quarters held 19 Through Q1 2020

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value

Quarterly position history

How this manager's reported quarter-end position changed over time.

0 quarters
Quarterly reported position history for TRILLIUM THERAPEUTICS INC held by BAKER BROS ADVISORS LP.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
This position's reported history falls outside the five-year preview window. A free account unlocks it. Unlock full history

Who else reported the position

66 managers reported TRILLIUM THERAPEUTICS INC for Q1 2020.

Managers reporting TRILLIUM THERAPEUTICS INC in Q1 2020.
Manager Activity Shares Change % of reported 13F Reported value Tenure
VR Adviser LLC New 6,790,000 +6,790,000 7.43% $27,432,000 1 qtr
RA CAPITAL MANAGEMENT L P New 6,361,446 +6,361,446 0.81% $25,700,000 1 qtr
NEA Management Company LLC Added 5,736,363 +3,636,363 1.21% $23,175,000 12 qtrs
Avoro Capital Advisors LLC New 4,950,000 +4,950,000 0.68% $19,998,000 1 qtr
Boxer Capital LLC New 4,075,000 +4,075,000 1.12% $16,463,000 1 qtr
CITADEL ADVISORS LLC New 3,443,234 +3,443,234 < 0.01% $13,911,000 3 qtrs
Marshall Wace North America L P New 2,587,961 +2,587,961 0.08% $10,455,000 1 qtr
DEUTSCHE BANK AG New 2,480,576 +2,480,576 < 0.01% $10,022,000 1 qtr
ALLIANCEBERNSTEIN L P New 2,363,767 +2,363,767 < 0.01% $9,550,000 1 qtr
Vivo Capital LLC New 2,054,468 +2,054,468 0.75% $8,300,000 1 qtr
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
March 31, 2020
Filed
May 15, 2020
Filing type
13F-HR
Position type
COM

Voting authority reported

No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.